来, 这个要修改的法律关系到我们所有人, 签抗议书吧

Quad

31Low concentration NHP
(1)
An NHP is a low concentration NHP if—
(a)
it is an NHP under section 29(2) or (4)(a); and
(b)
the concentration of every ingredient in it (other than an additive or formulation aid) is not more than 20 parts per million (or any lower concentration set out in the rules); and
(c)
it does not contain anything of human origin; and
(d)
it does not contain anything that is, or is derived from, an animal or part of an animal set out in the rules; and
(e)
it is not intended to be administered by injection or parenteral infusion or to the eye.
(2)
A therapeutic product is also a low concentration NHP if—
(a)
it is a therapeutic product under section 16(1)(a) or (b); and
(b)
it contains 1 or more ingredients (other than an additive or formulation aid) that are not NHP ingredients; and
(c)
it meets all the criteria in subsection (1)(b) to (e).
(3)
However, a product is not a low concentration NHP under subsection (2) if the rules say it is not.

Quad

是说用于治疗目的健康产品需要监管

Part 1
Preliminary provisions
3Purpose
The purpose of this Act is to protect, promote, and improve the health of all New Zealanders by providing for the—
(a)
acceptable safety, quality, and efficacy of medicines and APIs across their life cycle; and
(b)
acceptable safety, quality, and performance of medical devices across their life cycle; and
(c)
acceptable safety and quality of NHPs across their life cycle.